Relation between macroscopic binding constant and the anticancer efficacy of the bovine serum albumin-quercetin complex against drug-sensitive and drug-resistant cells

American Journal of Biochemistry and Biotechnology

Volumn 7, Issue 1, 2011, Pages 10-20

  Choiprasert, Winit ^a   Loetchutinat, Chatchanok ^a   Dechsupa, Nathupakorn ^a   Mankhetkorn, Samlee ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Anticancer; Flavonoids; Fluorescence resonance energy transfer (FRET); Serum albumin

Indexed keywords

ALCOHOLS; BINS; BODY FLUIDS; CELLS; CYTOLOGY; ENERGY TRANSFER; FLAVONOIDS; FLUORESCENCE; MOLECULES; PHENOLS; SOLUBILITY;

ANTICANCER; BINDING CONSTANT; BOVINE SERUM ALBUMINS; CELLULAR UPTAKE; FLUORESCENCE RESONANCE ENERGY TRANSFER; MACROSCOPIC BINDING; PROBLEM STATEMENT; SERUM ALBUMIN;

BINDING ENERGY;

BOVINE SERUM ALBUMIN; DOXYCYCLINE; DRUG CARRIER; PIRARUBICIN; QUERCETIN; QUERCETIN DERIVATIVE; QUERCETRIN; RUTOSIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG METABOLISM; DRUG SOLUBILITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOLECULE; PARTITION COEFFICIENT;

BOVINAE;

EID: 79960151223     PISSN: 15533468     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajbbsp.2011.10.20     Document Type: Article

References (33)

1. Ayudhya, N.S.N. and S. Mankhetkorn, 2009. Diatrizoate, Iopromide and Iotrolan Enhanced Cytotoxicity of Daunorubicin in Multidrug Resistant K562/adr Cells: Impaired the Mitochondrial and Inhibited the P-Glycoprotein Function. Am. J. Applied Sci., 6: 484-491. DOI: 10.3844/ajassp.2009.484.491
2. Choiprasert, W. and S. Mankhetkorn, 2006. Fluorescence resonance energy transfer study of quercetin and quercetrin interaction with bovine serum albumin in physiological solution: Determination of binding constants and binding sites. Proceeding of the 32nd Congress on Science and Technology of Thailand (STT.32), pp: 320. ISBN: 974-229-963-3
3. Choiprasert, W., N. Dechsupa, S. Kothan, M. Garrigos and S. Mankhetkorn, 2010. Quercetrin except rutin potentially increased pirarubicin cytotoxicity by non-competitively inhibiting the P-glycoproteinand MRP1 function in living K562/adr and GLC4/adr cells. Am. J. Pharmaco. Toxicol., 5: 24-33. DOI: 10.3844/ajptsp.2010.24.33
4. Dangles, O., C. Dufour and S. Bret, 1999. Flavonoserum albumin complexation. Two-electron oxidation of flavonols and their complexes with serum albumin. J. Chem. Soc. Perkin Trans., 2: 737-744. DOI: 10.1039/A901460H
5. Dechsupa S., S. Kothan, J. Vergote, G. Leger and A. Martineau et al., 2007. Quercetin, Siamois 1 and Siamois 2 Induce Apoptosis in Human Breast Cancer MDA-MB-435 Cells Xenograft in vivo. Cancer Bio. Therapy, 6: 56-61. DOI: 10.4161/cbt.6.1.3548
6. Dechsupa, N. and S. Mankhetkorn, 2009. PGlycoprotein-Mediated efflux and drug sequestration in lysosomes confer advantages of k562 multidrug resistance sublines to survive prolonged exposure to cytotoxic agents. Am. J. Applied Sci., 6: 1637-1646. DOI: 10.3844/ajassp.2009.1637.1646
7. Dufour, C. and O. Dangles, 2005. Flavonoid-serum albumin complication: Determination of binding constants and binding sites by fluorescence spectroscopy. Biochim. Biophys. Acta, 1721: 164-173. DOI: 10.1016/j.bbagen.2004.10.013
8. Garnier-Suillerot, A., C. Marbeuf-Gueye, M. Salerno, C. Loetchutinat and I. Fokt et al., 2001. Analysis of drug transport kinetics in multidrug-resistant cells: Implications for drug action. Curr. Med. Chem., 8: 51-64.
9. Hertog, M.G., P.M. Sweetnam, A.M. Fehily, P.C. Elwood and D. Kromhout, 1997. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am. J. Clin. Nutr., 65: 1489-1494. http://www.ajcn.org/content/65/5/1489.full.pdf+html
10. Hirvonen, T., P. Pietinen, M. Virtanen, M.L. Ovaskainen and S. Hakkinen et al., 2001. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology, 12: 62-67. http://www.jstor.org/stable/3703680
11. Iwanaga, K., T. Kushibiki, M. Miyazaki and M. Kakemi, 2006. Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs. Biol. Pharm. Bull., 29: 508-512. DOI: 10.1248/bpb.29.508
12. Jones, M.C., H. Gao and J.C. Leroux, 2008. Reverse polymeric micelles for pharmaceutical applications. J. Control Release, 132: 208-215. DOI: 10.1016/j.jconrel.2008.05.006
13. Kitson, T.M., 2004. Spectrophotometric and kinetic studies on the binding of the bioflavonoid quercetin to bovine serum albumin. Biosci. Biotechnol. Biochem., 68: 2165-2170. DOI: 10.1271/bbb.68.2165
14. Knekt, P., J. Kumpulainen, R. Jarvinen, H. Rissanen and M. Heliovaara et al., 2002. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 76: 560-568. http://www.ajcn.org/content/76/3/560.full.pdf+html
15. Kothan, S., S. Dechsupa, J.L. Moretti, J. Vergote and S. Mankhetkorn, 2004. Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562/R cells. Can. J. Physiol. Pharmacol., 82: 1084-1090. DOI: 10.1139/Y04-113
16. Kratz, F., 2008. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J. Controlled Release, 132: 171-183. DOI: 10.1016/j.jconrel.2008.05.010
17. Li, Y., H. Fang and W. Xu, 2007. Recent advance in the research of flavonoids as anticancer agents. Mini Rev. Med. Chem. 7: 663-678.
18. Lupidi, G., A. Scire, E. Camaioni, K.H. Khalife and G. De Sanctis et al., 2010. Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin. Phytomedicine, 17: 714-720. DOI: 10.1016/j.phymed.2010.01.011
19. Mink, P.J., C.G. Scrafford, L.M. Barraj, L. Harnack and C.P. Hong et al., 2007. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am. J. Clin. Nutr., 85: 895-909. http://www.ajcn.org/content/85/3/895.full.pdf+html
20. Mishra, B., A. Barik, K.I. Priyadarsini and H. Mohan, 2005. Fluorescence spectroscopic studies on binding of a flavonoid antioxidant quercetin to serum albumins. J. Chem. Sci., 117: 641-647. DOI: 10.1007/BF02708293
21. Moriyama, Y., D. Ohta, K. Hachiya, Y. Mitsui and K. Takeda, 1996. Fluorescence behavior of tryptophan residues of bovine and human serum albumins in ionic surfactant solutions: A comparative study of the two and one tryptophan(s) of bovine and human albumins. J. Protein Chem., 15: 265-272. DOI: 10.1007/BF01887115
22. Nia, Y., X. Zhang and S. Kokot, 2009. Spectrometric and voltammetric studies of the interaction between quercetin and bovine serum albumin using warfarin as site marker with the aid of chemometrics. Spectrochimica Acta Part A., 71: 1865-1872. DOI: 10.1016/j.saa.2008.07.004
23. Nijveldt, R.J., E. Van Nood, D.E.C. Van Hoorn, P.G. Boelens and K. van Norren et al., 2001. Flavonoids: A review of probable mechanisms of action and potential applications. Am. J. Clin. Nutrit., 74: 418-425. http://www.ajcn.org/content/74/4/418.full.pdf+html
24. Ramanouskaya, T.V., V.V. Smolnykova and V.V. Grinev, 2009. Relationship between structure and antiproliferative, proapoptotic and differentiation effects of flavonoids on chronic myeloid leukemia cells. Anticancer Drugs, 20: 573-583. DOI: 10.1097/CAD.0b013e32832d684c
25. Rimm, E.B., M.B. Katan, A. Ascherio, M.J. Stampfer and W.C. Willett, 1996. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann. Intern. Med., 125: 384-389. http://www.annals.org/content/125/5/384.full.pdf
26. Samanta, S.K. and K. Bhattacharya, 2010. Identification and quantification of the active component quercetin 3-O-rutinoside from Barringtonia racemosa, targets mitochondrial apoptotic pathway in acute lymphoblastic leukemia. J. Asian Natural Products Res., 12: 639-648. ISSN: 1477-2213
27. Tian, J., J. Liu, W. He, Z. Hu, X. Yao and X. Chen, 2004. Probing the binding of scutellarin to human serum albumin by circular dichroism, fluorescence spectroscopy, FTIR and molecular modeling method. Biomacromolecules, 5: 1956-1961. DOI: 10.1021/bm049668m
28. Tungjai, M., W. Poompimon, C. Loetchutinat, S. Kothan and N. Dechsupa et al., 2008. Spectrophotometric characterization of behavior and the predominant species of flavonoids in physiological buffer: Determination of solubility, lipophilicity and anticancer efficacy. Open Drug Deliv. J., 2: 10-19. http://www.benthamscience.com/open/toddj/articles/V002/10TODDJ.pdf
29. Varshney, A., P. Sen, E. Ahmad, M. Rehan and N. Subbarao et al., 2010. Ligand binding strategies of human serum albumin: How can the cargo be utilized? CHIRALITY, 22: 77-87. DOI:10.1002/chir.20709
30. Wang, L., Y.C. Tu, T.W. Lian, J.T. Hung and J.H. Yen et al., 2006. Distinctive Antioxidant and Antiinflammatory Effects of Flavonols. J. Agric. Food Chem., 54: 9798-9804. DOI: 10.1021/jf0620719
31. Watanabe, M., K. Kawano, K. Toma Y. Hattori and Y. Maitani, 2008. In vivo antitumor activity of camptothecin incorporated in liposome's formulated with an artificial lipid and human serum albumin. J. Control Release, 127: 231-238. DOI: 10.1016/j.jconrel.2008.02.005
32. Yochum, L., L.H. Kushi, K. Meyer and A.R. Folsom, 1999. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am. J. Epidemiol., 149: 943-949. http://aje.oxfordjournals.org/content/149/10/943.full.pdf+html
33. Yue, Y., X. Chen, J. Qin and X. Yao, 2009. Spectroscopic investigation on the binding of antineoplastic drug oxaliplatin to human serum albumin and molecular modeling. Colloids Surf. B Biointerfaces, 69: 51-57. DOI: 10.1016/j.colsurfb.2008.10.016